The Patent Finder

Hangzhou Innogate Pharma Co., Ltd.

Also on record
Records under this name other than the patents Hangzhou Innogate Pharma Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.

Showing 1 to 2 of 2 · Back to Hangzhou Innogate Pharma Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,225,492Heterocycles useful as anti-cancer agents
Lapsed on the fee record
Ended Jan 18, 2026 · USPTO record
Lapsed on the fee recordEnded Jan 18, 2026USPTO record
US 10,934,311Heterocyclic compound used as FGFR inhibitor
Lapsed on the fee record
Ended Mar 2, 2025 · USPTO record
Lapsed on the fee recordEnded Mar 2, 2025USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited